Endoscopic implant system and method

You’ve invested time, talent, and energy into making a dent in the universe with your invention and ideas. Now it’s time for Utility, Provisional or Design Patent Creation with PowerPatent software and services.

The Boston Scientific Scimed, Inc. patent solves the following problem:

An anatomical view of a human stomach S and associated parts shown in FIG. 1. The esophagus E delivers food from the mouth to the proximal portion of the stomach S. The z-line or gastro-esophageal junction Z is the irregularly-shaped border between the thin tissue of the esophagus and the thicker tissue in the abdominal wall. The gastro-esophageal junction region G is the region around the distal portion of the esophagus S, the z-line, and the proximal portion of the stomach S.

Our analysis of this patent is as follows:

Boston Scientific Scimed, Inc.’s patent US 9456825 B2 deals with Endoscopic implant system and method.
Disclosed is a system for endoscopically implanting a medical implant, including an anchor, in a body cavity such as the side of the gastroesophageal junction in one stomach. The system includes one or more anchors positionable in one or more openings formed in the tissues in the body cavity, like a cutout formed in plicated body tissue. Tools expressing the positioning of anchors in the door, and for coupling a restrictor food anchors.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.

Recombinant proteins that simultaneously bind HGF, VEGF-A and serum albumin, comprising ankyrin repeat domains

You’ve invested time, talent, and energy into making a dent in the universe with your invention and ideas. Now it’s time to make sure it’s protected with a PowerPatent Utility, Provisional or Design Patent Application

The Molecular Partners Ag patent solves the following problem:

The following discussion of the background is only provided to assist readers in understanding the invention and is not admitted to describe or constitute prior art to the present invention.

Our analysis of this patent is as follows:

Molecular Partners Ag’s patent US 9458211 B1 deals with Recombinant proteins that simultaneously bind HGF, VEGF-A and serum albumin, comprising ankyrin repeat domains.
Bag-ong designed ankyrin repeat domains with binding specificity for serum albumin, artificial binding protein that contains at least two designed ankyrin repeat domains with binding specificity for serum albumin, as well as artificial binding protein that contains the at least a designed ankyrin repeat domains with binding specificity for hepatocyte growth factor (HGF), at least a designed ankyrin repeat domains with binding specificity for vascular endothelial growth that (VEGF-A), and at least two designed ankyrin repeat domains with binding specificity for serum albumin described, as well as nucleic acid encoding the designed ankyrin repeat domains and artificial binding proteins, pharmaceutical compositions containing the designed ankyrin repeat domains, artificial binding protein or nucleic acid and to use those designed ankyrin repeat domains, artificial binding protein, nucleic acid composition or medicine to treat the disease.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.

Kits for systems and methods using acoustic radiation pressure

Protect your idea by filing a Provisional or Utility Patent Application with the PowerPatent Patent Service. It’s easy and fully backed by patent lawyers – and you don’t have to pay until you’re done.

The Life Technologies Corporation patent solves the following problem:

Embodiments of the present invention relate to systems using acoustic radiation pressure.

Our analysis of this patent is as follows:

Life Technologies Corporation’s patent US 9457139 B2 deals with Kits for systems and methods using acoustic radiation pressure.
A kit of reagents for use in an acoustic apparatus includes a first fluid that is a lysis fluid, a second fluid having an acoustic difference greater than the first fluid, and a reagent for the calling of a particle.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.

Grid patterned alignment plate for imaging apparatus and method of providing implant placement

Use PowerPatent’s Online Patent Filing Service to get quick patent protection for your great idea.

The OrthoGrid Systems, Inc patent solves the following problem:

Many radiographic parameters important in total hip arthroplasty (THA) component performance, such as ob, and strength, can assess intraoperatively fluoroscopy. But even with intraoperative fluoroscopic guidance, the placement of an implant or reduction of bone fragments may still not be as close as determined by the surgeon. For example, the mal-positioning of the acetabular component during hip arthroplasty leads to problems. For the acetabular implant which is inserted in the correct position relative to the pelvis during hip arthroplasty requires the surgeon to know the position of the patient's pelvis during the operation. Unfortunately, the position of the pelvis in patients varies widely during the operation and from patient to patient. During the operation trauma, fracture management, especially in the case of an intra-articular fracture, requires a surgeon to reduce bone fragments confidence with respect to the original anatomy to: provide anatomical others combined the best chance to rehabilitate properly; further reduce long-term damage and, if possible, also to its normal function. Sadly, in a reverse situation, the original anatomical position of the bone fragments compromised and their natural relationship with the correct anatomy is uncertain and requires the surgeon to use his / her best judgment to develop a successful repair and subsequent positive result.

Our analysis of this patent is as follows:

OrthoGrid Systems, Inc’s patent US 9456874 B2 deals with Grid patterned alignment plate for imaging apparatus and method of providing implant placement.
A computer-implemented system for adjusting the placement of an implant in a patient by using a template dimensioned grid placed relative to patient anatomy in a fluoroscopic machine and a method of digital measuring parameters adaptation given. This system can be used to determine: 1) leg length, offset and cup position during arthroplasty in place of operation; 2) fracture reduction / correction position during the procedure trauma and 3) a tool used for deformity correction given planning; 4) placement and positioning of instruments and implants relative to bones and anatomical architecture; 5) standard bone anatomy border identification relative to reaming and cutting bone landmarks.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.

Physical therapy whole sound frequencies device and method of recording content used therein

Patent Registration – Protect your earth-moving ideas with PowerPatent software service for Online Patent Application

The Vincent J. Lasorso, Jr. patent solves the following problem:

invention generally relates to individual health and well-being based on the vibrational energy, and especially related to physical and auditory stimulation of biological tissue with absolute voice frequency and harmonics.

Our analysis of this patent is as follows:

Vincent J. Lasorso, Jr.’s patent US 9457166 B1 deals with Physical therapy whole sound frequencies device and method of recording content used therein.
The present invention includes a device and method for relaxing and promote the healing of a man with synchronized in all actions and aural tone sounds.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.

Recombinant antibodies against H1N1 influenza

Patent Registration – Protect your earth-moving ideas with PowerPatent software service for Online Patent Application

The Emory University, , The University Of Chicago patent solves the following problem:

The swine H1N1 influenza virus now causing a global pandemic associated with substantial morbidity and mortality1-5. This newly emergent strain is immunologically different from other influenza viruses including the new H1N1 strains6 thus leaving a large population of the world are very susceptible to infection of pandemic virus7. Although there are some B cell cross-reactivity with seasonal influenza virus protective epitopes swine H1N1 virus so that race.

Our analysis of this patent is as follows:

Emory University, , The University Of Chicago’s patent US 9458226 B2 deals with Recombinant antibodies against H1N1 influenza.
Antibodies that bind with high affinity to the swine H1N1 virus described. In vivo experiments showed that the antibody could completely protect the mice were challenged with a lethal dose of the swine H1N1 virus. antibody is able to cure mice in a therapeutic situation when treated as late as 60 hours (2.5 days) after the infection with swine H1N1 virus. Also described the artificial kind of antibody.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.

Methods for producing enteroendocrine cells that make and secrete insulin

You’ve invested time, talent, and energy into making a dent in the universe with your invention and ideas. Now it’s time to make sure it’s protected with a PowerPatent Utility, Provisional or Design Patent Application

The The Trustees Of Columbia University In The City Of New York patent solves the following problem:

Methods for treating and preventing type 1 and 2 diabetes.

Our analysis of this patent is as follows:

The Trustees Of Columbia University In The City Of New York’s patent US 9457079 B2 deals with Methods for producing enteroendocrine cells that make and secrete insulin.
Methods described in enteroendocrine cells and secrete insulin in a mammal by blocking the expression or biological activity of one or more Foxo protein or biologically active fragments or race.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.

Human monoclonal antibodies to epidermal growth factor receptor (EGFR)

Be the First-to-File and Protect your earth-moving ideas with PowerPatent software service for Online Patent Application

The Genmab A/S patent solves the following problem:

The EGF receptor (EGFR) is a 170 kDa type 1 transmembrane molecules. The expression found upregulated in many human tumors including carcinoma of the head and neck, breast, colon, prostate, lung, and ovaries. The kind of over-expression correlated with poor clinical prognosis (Baselga, et al (1994) Pharmac therapeut 64: ….. 127-154; Modjtahedi, et al (1994) Int J. Oncology 4: 277-296). Furthermore, his expression always accompanied by the production of EGFR ligands, TGF- and EGF among others, by EGFR-expressing tumor cells suggests that an autocrine loop participates in growth this cells (Baselga, et al. (1994) Pharmac therapeut 64: …. 127-154; Modjtahedi, et al (1994) Int J. Oncology 4: 277-296) .. Ali interaction between such EGFR ligands and EGFR therefore can inhibit tumor growth and survival (Baselga, et al (1994) Pharmac therapeut 64: 127-154).

Our analysis of this patent is as follows:

Genmab A/S’s patent US 9458236 B2 deals with Human monoclonal antibodies to epidermal growth factor receptor (EGFR).
Isolated human monoclonal antibody that specifically binds to human EGFR, and related antibody-based compositions and molecules, are disclosed. The human antibody can be produced in a transfectoma or a non-human transgenic animals, for example, a transgenic mouse, capable of producing multiple isotypes of human monoclonal antibodies by undergoing VDJ recombination and isotype switch. also discloses pharmaceutical compositions comprising the human antibodies, non-human transgenic animals and hybridomas that produce human antibodies, and therapeutic and diagnostic methods using human antibody.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.

Audio encoder for wind and microphone noise reduction in a microphone array system

Patent Registration – Protect your earth-moving ideas with PowerPatent software service for Online Patent Application

The Gopro, Inc. patent solves the following problem:

It disclosure relates to audio processing, and more specifically, the encoding and decoding of audio signal before the microphone and wind noise.

Our analysis of this patent is as follows:

Gopro, Inc.’s patent US 9460727 B1 deals with Audio encoder for wind and microphone noise reduction in a microphone array system.
An audio encoding system and decodes audio captured by a microphone system battle before the wind noise. encoder The encoding of the audio signal in a way that includes beamformed audio signal and a secret representation of a non-beamformed audio signal. The secret signal to the modulating low frequency signal into a high frequency above the audible range. A decoder can then output the beamformed audio signal or you can use the secret signal to produce a reduction in wind noise audio signal that includes non-beamformed audio in the low frequency range.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.

Methods and devices for spinal correction

Patent Registration – Protect your earth-moving ideas with PowerPatent software service for Online Patent Application

The DePuy Synthes Products, Inc. patent solves the following problem:

The human spine is a series of strong vertebral bodies separated by flexible plates called intervertebral discs. The plate consists of a compressible, flexible jelly-like center called the nucleus pulposus. FLEXIBILITY This allows the spine to bend and twist. The annulus fibrosus is a strong, fibrous material around and up the center, which can be extruded into other parts of the body.

Our analysis of this patent is as follows:

DePuy Synthes Products, Inc.’s patent US 9456817 B2 deals with Methods and devices for spinal correction.
An expandable test may include a lower, a greater portion, and a middle expansion phase as well as load cells to monitor the load test. Tests may also include recesses on the lateral side of the give-and to accommodate a disc tissue removal device to be cleared monitoring load. Furthermore, nerve foramen and may monitor to provide information about how many nerves release achieved as the disc cleaned and spine position and repositioned.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.